Need professional-grade analysis? Visit stockanalysis.com
$43.80B
6.67
49,608
4.01%
Shanghai Pharmaceuticals Holding Co Ltd (2607) trades on Hong Kong Stock Exchange in HKD. The company is classified in the Healthcare sector under the Medical Distribution industry. The stock currently trades at HKD11.78, up 1.20% from the previous close.
Over the past year, 2607 has traded between a low of HKD10.21 and a high of HKD12.69. The stock has gained 12.6% over this period. It is currently 7.2% below its 52-week high.
Shanghai Pharmaceuticals Holding Co Ltd has a market capitalization of $43.80B, with a price-to-earnings ratio of 6.67 and a dividend yield of 4.01%.
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical and healthcare products in China and internationally. The company operates through four segments: Production, Distribution, Retail, and Others. It offers chemical and biological drugs, Chinese medicine, health care products, and medical devices to treat immunology, psychiatric and neurological, tumor, cardiovascular, digestive metabolism, psychoneurotic, neoplasm, respiratory system, and anti-infection diseases, as well as invests in equity. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores. Shanghai Pharmaceuticals Holding Co., Ltd. was incorporated in 1994 and is headquartered in Shanghai, China.
Side-by-side comparison against top Healthcare peers.